tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haleon PLC Executes Share Buyback to Enhance Shareholder Value

Story Highlights
Haleon PLC Executes Share Buyback to Enhance Shareholder Value

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Haleon PLC Sponsored ADR ( (HLN) ) has issued an update.

On August 11, 2025, Haleon PLC announced the purchase and cancellation of 856,760 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, which took place on August 8, 2025, reflects Haleon’s strategic focus on enhancing shareholder value and optimizing its capital structure, potentially strengthening its market position and impacting stakeholders by adjusting the number of shares with voting rights to 8,975,855,583.

The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.

Haleon PLC’s overall stock score of 65 reflects a mixed outlook. Strong financial performance and strategic investments are offset by bearish technical signals and regional sales challenges, particularly in North America. The company’s valuation is moderate, aligning with its growth prospects. Continued focus on innovation and market expansion could enhance its position, but near-term challenges need to be addressed.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company offers a diverse range of products across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon’s portfolio features well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, all of which are grounded in trusted science and innovation.

Average Trading Volume: 14,850,313

Technical Sentiment Signal: Hold

Current Market Cap: $42.9B

For an in-depth examination of HLN stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1